Biography

Joseph L. Goldstein is currently Chairman of the Department of Molecular Genetics at UT Southwestern Medical Center. In 1985, he was named Regental Professor of the University of Texas. He also holds the Paul J. Thomas Chair in Medicine and the Julie and Louis A. Beecherl Distinguished Chair in Biomedical Science. Dr. Goldstein and his colleague, Michael S. Brown, discovered the low density lipoprotein (LDL) receptor and worked out how these receptors control cholesterol homeostasis. At the basic level, this work opened the field of receptor-mediated endocytosis, and at the clinical level it helped lay the conceptual groundwork for development of drugs called statins that lower blood LDL-cholesterol and prevent heart attacks.

Drs. Goldstein and Brown shared many awards for this work, including the Lasker Award in Basic Medical Research (1985), Nobel Prize in Physiology or Medicine (1985), and National Medal of Science (1988). In recent work, Drs. Goldstein and Brown discovered the SREBP family of transcription factors and showed how these membrane-bound molecules control the synthesis of cholesterol and fatty acids through a newly described process of Regulated Intramembrane Proteolysis. For this work, Drs. Brown and Goldstein received the Albany Medical Center Prize in Medicine and Biomedical Research (2003).

Dr. Goldstein is currently Chairman of the Albert Lasker Medical Research Awards Jury and is a member of the Boards of Trustees of the Howard Hughes Medical Institute and The Rockefeller University. He also serves on the Scientific Advisory Boards of the Welch Foundation, Memorial Sloan-Kettering Cancer Center, Scripps Research Institute, Van Andel Institute, and the Massachusetts General Hospital. He is a member of the US National Academy of Sciences and a Foreign Member of the Royal Society.

 

Education

Undergraduate
Washington and Lee University (1962)
Medical School
UT Southwestern Medical Center (1966)

Research Interest

  • Cholesterol and Lipoprotein Metabolism
  • Genetics of Human Disease

Publications

Featured Publications LegendFeatured Publications

Triazoles inhibit cholesterol export from lysosomes by binding to NPC1.
Trinh MN, Lu F, Li X, Das A, Liang Q, De Brabander JK, Brown MS, Goldstein JL Proc. Natl. Acad. Sci. U.S.A. 2016 Dec
Insulin induction of SREBP-1c in rodent liver requires LXRa-C/EBPß complex.
Tian J, Goldstein JL, Brown MS Proc. Natl. Acad. Sci. U.S.A. 2016 Jul 113 29 8182-7
Direct Demonstration that Loop1 of Scap Binds to Loop7, a crucial event in cholesterol homeostasis.
Zhang Y, Lee KM, Kinch LN, Clark L, Grishin NV, Rosenbaum DM, Brown MS, Goldstein JL, Radhakrishnan A J. Biol. Chem. 2016 Apr
Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection.
Lu F, Liang Q, Abi-Mosleh L, Das A, De Brabander JK, Goldstein JL, Brown MS Elife 2015 Dec 4
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins.
Goldstein JL, Brown MS Cell 2015 Mar 161 1 161-172

Honors & Awards

  • Rolf Luft Prize
    (2016)
  • Earl and Thressa Stadtman Distinguished Scientist Award
    (2011)
  • Albany Medical Center Prize in Biomedical Research
    (2003)
  • Warren Alpert Foundation Prize
    (2000)
  • U.S. National Medal of Science
    (1988)
  • Albert D. Lasker Award in Basic Medical Research
    (1985)
  • Nobel Prize In Physiology or Medicine
    (1985)

Professional Associations/Affiliations

  • American Philosophical Society
  • Association of American Physicians
  • Institute of Medicine
  • Royal Society (London)
  • U.S. National Academy of Sciences